UPL Ltd Q4 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/gngc5osqbcj29twy6r7bracx.pdf

Key Takeaways


The Quarter in Detail: Growth, Provision & Quality

Ravishankar Cherukuri: "We preserved our revenue in the face of many headwinds. … Despite all of that stuff, we scaled up the brands that we focused on in a way that we ended up preserving our revenue while significantly improving our contribution by 19% and EBITDA by 24%."

Balance Sheet & Capital Structure

Bikash Prasad: "So if we don't report it in probably properly and the right way to look at it in the constant currency and the dollars, it will be misleading you and it will not give you the right perception."

Platform Performance

PlatformRevenue TrendKey Driver
Advanta▲ 23% YoYVolume +12%, price +6%, forex +5%; growth balanced across four continents and five crop segments. Now a top-10 global seed company.
UPL Corp▲ 11% YoYVolume-led growth amid global uncertainty, with broad-based regional contribution.
India SAS▬ FlatRevenue preserved despite brand phase-outs, monsoon impact and price erosion; contribution and EBITDA up sharply on mix.
SUPERFORM▬ Flat (1%)Top line suppressed by falling input prices passed through in the CMO cost-plus model, but specialty share rose from 20% to 28%, lifting contribution margin 240 bps to 24.7%.
Bhupen: "What is our core is rather than having patchy growth scenario, we look for resilient and consistent growth year after year, which you can see last 10 years track record of Advanta."

Innovation, NPP & the Pipeline


Reorganization & Value Unlocking

Jaidev Shroff: "These companies are going to grow at least 3x-4x the other players you've ever seen in this space growing."

Market Environment & Risk Management

Raj Tiwari: "We don't punt, we don't believe in speculations. And therefore, we should be able to pass on whatever the cost increase has been there."

Guidance & Commitments

CommitmentSpecificsTimeline
Q1 FY27 revenue growth10% to 14% YoY; positive price impact across most platforms; FX positive 7–9%Q1 FY27
Q1 FY27 EBITDA growth14% to18% YoY; 6–7% currency impact at EBITDA levelQ1 FY27
Innovation rateCloser to 18% (products introduced in last 5 years)End-FY27
NPP revenueClose to $700 mnFY27
SUPERFORM Ag/Specialty mixShift from 72/28 to 60/40Next 48 months
SUPERFORM specialty EBITDA margin~20% for the business at that mixNext 48 months
Group gearing target1.2x to1.5x; below 1.5x, likely to stay at that levelMedium-term
FY27 capex$300–350 mn (~$325 mn), driven by specialty chemicals and backward integrationFY27
FY27 ETR~20–22%FY27
Net debt/EBITDAComfortably within or less than 1.5xOngoing
Working capital cycle time~65 days going forwardOngoing
Crop protection pipeline actualization~$1.5 bn of ~$4.4 bn peak-sales pipelineBy FY30
NPP revenue targetClose to $1 bnBy FY31

Key Metrics

MetricQ4 FY26
Revenue₹52,000 cr (FY26), +11% YoY, largely volume-led
Revenue growth+18% YoY, over a stellar Q4 FY25 base
EBITDA+13% YoY
EBITDA margin19.9%; would have been ~22% excluding a ₹350 cr provision for doubtful debt (per an analyst's math)
PATMI (net income)+18% YoY
Contribution marginImproved ~50 bps YoY
SG&A+27% YoY, includes ₹350 cr provision for doubtful debt
Gross debt$2.3 bn (FY26), reduced by $850 mn in FY26; down 40% from $3.8 bn in FY24
Net debt$1.6 bn (FY26), reduced by $400 mn in FY26; down 48% from $3.1 bn in FY24
Gearing ratio (Net debt/EBITDA)Below 1.6x, better than guidance; FY25: 2.1x, FY24: 4.6x
Return on EquityAlmost doubled vs last year
Working capital cycle time57 days, marginally up 4 days YoY; management comfortable at ~65 days
Capex$261 mn (FY26), vs guidance of ~$250 mn
UPL Corp revenue growth+11% YoY (FY26)
Advanta revenue growth+23% YoY (FY26)
India SAS revenueFlat (FY26), due to monsoon effect
SUPERFORM revenue₹10,298 cr (FY26), +1% YoY; specialty chemicals share moved from 20% to 28%
Innovation rate16% (FY26), up from 14% in FY25; products introduced within last 5 years
Revenue from new product launchesOver $160 mn (FY26), ~4% of total revenue; exceeded target of ~$130 mn
NPP revenue targetClose to $700 mn expected in FY27; confident of ~$1 bn by FY31
Q1 FY27 revenue growth guidance10% to 14% YoY
Q1 FY27 EBITDA growth guidance14% to 18% YoY
FY27 capex guidance$300–350 mn
FY27 effective tax rate guidance20–22%